IMPACT OF DIABETES MELLITUS ON THE PREDICTIVE VALUE OF CARDIAC I-123 METAIODOBENZYLGUANIDINE IMAGING ON MODE OF DEATH IN PATIENTS WITH CHRONIC HEART FAILURE  by Tamaki, Shunsuke et al.
Non Invasive Imaging (Echocardiography, Nuclear, PET, MR and CT)
A1280
JACC March 17, 2015
Volume 65, Issue 10S
imPAct of diABetes mellitus on the Predictive vAlue of cArdiAc i-123 
metAiodoBenzYlguAnidine imAging on mode of deAth in PAtients With chronic heArt 
fAilure
Poster Contributions
Poster Hall B1
Sunday, March 15, 2015, 3:45 p.m.-4:30 p.m.
Session Title: Non Invasive Imaging: Advances in Nuclear Imaging
Abstract Category: 19.  Non Invasive Imaging: Nuclear
Presentation Number: 1208-043
Authors: Shunsuke Tamaki, Takahisa Yamada, Takashi Morita, Yoshio Furukawa, Yusuke Iwasaki, Masato Kawasaki, Atsushi Kikuchi, 
Takumi Kondo, Tsutomu Kawai, Satoshi Takahashi, Masashi Ishimi, Hideyuki Hakui, Tatsuhisa Ozaki, Yoshihiro Sato, Masahiro Seo, 
Masatake Fukunami, Osaka General Medical Center, Osaka, Japan
Background: Cardiac I-123 metaiodobenzylguanidine (MIBG) imaging provides prognostic information in patients with chronic heart failure 
(CHF), and diabetes mellitus (DM) has been shown to influence the results of cardiac MIBG imaging. Prediction of mode of death may 
facilitate decisions about specific medications or device therapies. However, little is known about the impact of DM on the predictive value 
of the cardiac MIBG imaging on mode of death in CHF patients.
methods: In 113 CHF outpatients with radionuclide left ventricular ejection fraction <40% (29.6±7.6%), cardiac MIBG washout rate (WR) 
was calculated from the chest anterior view images obtained at 20 and 200 min after isotope injection. Abnormal WR was defined as WR 
>27%.
results: During the follow up period of 8.0±4.6 years, sudden death was observed in 7 of 33 DM patients and in 16 of 80 non-DM patients, 
and pump failure death (PFD) was observed in 5 of 33 DM patients and in 10 of 80 non-DM patients. There was no significant difference in 
the risk of sudden death between the DM patients with abnormal WR and those with normal WR, while non-DM patients with abnormal WR 
had a significantly higher risk of sudden death than those with normal WR. Abnormal WR was associated with significantly higher risk of 
PFD both in the DM and non-DM patients (Figure).
conclusion: Although cardiac MIBG imaging might lack the power to predict the risk of sudden death in the presence of DM, usefulness of 
cardiac MIBG for the prediction of PFD might not be influenced by DM in CHF patients.
 
